From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
This four-part online training course helps nurses, midwives and sexual health workers understand the public health aspects and clinical management of common STIs, HIV and hepatitis B. The course helps participants develop confidence in a proactive and practical approach to health care and evidence-based practice. This course is for healthcare professionals practicing in NSW. We […]
This training aims to provide participants with the confidence to initiate conversations around hepatitis C in the needle and syringe program (NSP) setting and provide referrals to testing and treatment. This course is for healthcare professionals practicing in VIC. While others are welcome to register, please note some content will be specific to VIC. Date, Time, Platform: Date: Wednesday, […]
From 14-17 August 2026, five healthcare professionals selected for the HBV s100 Prescriber Scholarship attended the 16th Australasian Viral Hepatitis Conference (VH2026) in Walyalup (Fremantle). Over three days, scholarship recipients learnt about the latest developments and work happening across the region in viral hepatitis care, and connected with leading experts and fellow healthcare professionals at networking events, including the official Scholarship Meetup. Read the below reflections from these scholarship recipients as they explore their experiences […]
From 12-14 August 2026, the 16th Australasian Viral Hepatitis Conference (VH2026) took place in Walyalup (Fremantle), on the traditional lands of the Whadjuk Noongar people. The conference brought together people living with hepatitis, peers, nurses, GPs, specialists, researchers and decision-makers to share practical, evidence-informed solutions that strengthen prevention, testing, treatment and long-term care in every setting. Cherie Bennett, Nursing Policy and Advocacy Lead at ASHM, reflects on the […]
People accessing alcohol and other drug (AOD) services are disproportionately affected by hepatitis C, yet many continue to face barriers to testing, treatment and ongoing care. AOD services and needle and syringe programs are uniquely positioned to change this, playing a critical role in Australia’s hepatitis C elimination efforts. Join colleagues from across the AOD and health […]
Course Overview People who live with blood-borne viruses (BBV) often experience stigma when interacting with healthcare workers. Stigma can keep people from getting appropriate healthcare and support. It’s often driven by a misunderstanding of the risks that you face in your work. This module will help you understand the facts about HIV, hepatitis B (hep […]
This module provides the background and practical information needed on how to take capillary blood samples for dried blood spot (DBS) testing for hepatitis C under guidance by NSW Health. The module is intended for clinicians, health promotion staff, peer workers and others who are completing the sample collection process. DBS testing was approved by the Therapeutic Goods […]
An introduction to this year’s C the Whole Story theme When we talk about “culturally safe” hepatitis C virus (HCV) care, what do we really mean? And how can creating a culturally safe environment improve treatment outcomes for people living with HCV? These questions form the foundation of this year’s C the Whole Story Forum, […]
Overnight in 2016, the treatment of hepatitis C virus (HCV) in Australia changed forever through the introduction of Direct-acting antivirals (DAAs) to the Australian Pharmaceutical Benefits Scheme (PBS). This month marks ten years since this vital turning point. Prior to this, treatment for HCV typically took place in a hospital setting and scripts had to be written by a […]
People living with a blood-borne virus (BBV) in Australia experience legal issues at significantly higher rates than those without and commonly face multiple and overlapping legal problems at once. These findings come from Health+Law’s Legal Needs Study, which also found the majority of participants report their most serious legal issues are linked to, or worsened by, living with a BBV. As […]